Artificial Intelligence-Driven Prognostic Classification of COVID-19 Using Chest X-rays: A Deep Learning Approach
It addresses the need for scalable and efficient AI tools to assist in rapid patient prognosis during the COVID-19 pandemic, though it is incremental as it applies existing deep learning methods to this specific domain.
This study tackled the problem of classifying COVID-19 severity (Mild, Moderate, Severe) from chest X-ray images using a deep learning model, achieving an average accuracy of 97% with specific class accuracies ranging from 81.16% to 95.77%.
Background: The COVID-19 pandemic has overwhelmed healthcare systems, emphasizing the need for AI-driven tools to assist in rapid and accurate patient prognosis. Chest X-ray imaging is a widely available diagnostic tool, but existing methods for prognosis classification lack scalability and efficiency. Objective: This study presents a high-accuracy deep learning model for classifying COVID-19 severity (Mild, Moderate, and Severe) using Chest X-ray images, developed on Microsoft Azure Custom Vision. Methods: Using a dataset of 1,103 confirmed COVID-19 X-ray images from AIforCOVID, we trained and validated a deep learning model leveraging Convolutional Neural Networks (CNNs). The model was evaluated on an unseen dataset to measure accuracy, precision, and recall. Results: Our model achieved an average accuracy of 97%, with specificity of 99%, sensitivity of 87%, and an F1-score of 93.11%. When classifying COVID-19 severity, the model achieved accuracies of 89.03% (Mild), 95.77% (Moderate), and 81.16% (Severe). These results demonstrate the model's potential for real-world clinical applications, aiding in faster decision-making and improved resource allocation. Conclusion: AI-driven prognosis classification using deep learning can significantly enhance COVID-19 patient management, enabling early intervention and efficient triaging. Our study provides a scalable, high-accuracy AI framework for integrating deep learning into routine clinical workflows. Future work should focus on expanding datasets, external validation, and regulatory compliance to facilitate clinical adoption.